- Home
- OMH vs CNSP Comparison
OMH vs CNSP Comparison
Compare OMH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- CNSP
- Stock Information
- Founded
- OMH 2015
- CNSP 2017
- Country
- OMH Singapore
- CNSP United States
- Employees
- OMH N/A
- CNSP N/A
- Industry
- OMH Real Estate
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- CNSP Health Care
- Exchange
- OMH Nasdaq
- CNSP Nasdaq
- Market Cap
- OMH 5.1M
- CNSP 5.6M
- IPO Year
- OMH 2023
- CNSP 2019
- Fundamental
- Price
- OMH $3.05
- CNSP $1.14
- Analyst Decision
- OMH Strong Buy
- CNSP Hold
- Analyst Count
- OMH 1
- CNSP 1
- Target Price
- OMH $15.00
- CNSP N/A
- AVG Volume (30 Days)
- OMH 4.7M
- CNSP 133.9K
- Earning Date
- OMH 06-26-2025
- CNSP 05-20-2025
- Dividend Yield
- OMH N/A
- CNSP N/A
- EPS Growth
- OMH N/A
- CNSP N/A
- EPS
- OMH N/A
- CNSP N/A
- Revenue
- OMH $7,976,578.00
- CNSP N/A
- Revenue This Year
- OMH $28.40
- CNSP N/A
- Revenue Next Year
- OMH N/A
- CNSP N/A
- P/E Ratio
- OMH N/A
- CNSP N/A
- Revenue Growth
- OMH 117.53
- CNSP N/A
- 52 Week Low
- OMH $0.25
- CNSP $0.77
- 52 Week High
- OMH $4.33
- CNSP $800.00
- Technical
- Relative Strength Index (RSI)
- OMH 56.68
- CNSP 42.51
- Support Level
- OMH $2.79
- CNSP $1.08
- Resistance Level
- OMH $3.75
- CNSP $1.15
- Average True Range (ATR)
- OMH 0.61
- CNSP 0.08
- MACD
- OMH 0.01
- CNSP 0.08
- Stochastic Oscillator
- OMH 51.33
- CNSP 96.88
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.